İçeriğe geç
akaturk Akademik ölçüm

OpenAlex konusu

Advanced Drug Delivery Systems

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 2.026 eser 132 yazar konusu

Çalışmalar

2.026 eser

  1. Pharmacokinetics of oral and subcutaneous administration of free and liposomal levamisole in goats 2026

    Özet henüz yok.

  2. Sobetirome‐Loaded Chitosan Nanoparticles for Controlled Release and Enhanced Blood–Brain Barrier Permeability in Neurodegenerative Disorders 2026

    Neurodegenerative diseases represent a major global health challenge due to their progressive nature and lack of curative therapies. Developing innovative strategies to protect and regenerate neuronal structures is therefore crucial. In recent years, Sobetirome, a synthetic thyromimetic compound, has emerged as a prom…

  3. Development and Optimization of an Eplerenone-Loaded Liposomal In Situ Gel for Enhanced Intranasal Delivery 2026

    Objectives: this study aimed to develop and optimize an intranasal delivery system for Eplerenone (EPL) by incorporating Eplerenone-loaded liposomes (Elip) into an in situ gel system (Elip-GG). The goal was to prolong the residence time of the drug in the nasal cavity and ensure sustained release. Methods: Elip and un…

  4. Nanoparticle Strategies for Enhanced Protein and Peptide Drug Delivery 2026

    The delivery of protein and peptide therapeutics presents substantial challenges due to their inherent instability, vulnerability to enzymatic degradation, and low bioavailability. Nanoparticle-based delivery systems offer promising solutions, providing protection, controlled release, and targeted delivery for these t…

  5. Advanced skin delivery systems: Formulation strategies, therapeutic potential and patent perspectives 2026

    Özet henüz yok.

  6. Development of nanoparticle-hydrogel drug delivery system for sustained release of anti-VEGF peptide in ocular neovascularization treatment 2026

    Vascular Endothelial Growth Factor (VEGF) is a critical factor in pathological neovascularization, making it the primary target for ocular anti-angiogenic therapies. Anti-VEGF treatments suffer from requiring frequent intraocular injections for effective treatment due to limited half-life. This study aimed to utilize…

  7. Development of Nanoparticle‐Hydrogel Drug Delivery System for Sustained Release of Anti‐VEGF Peptide in Ocular Neovascularization Treatment 2026

    Vascular Endothelial Growth Factor (VEGF) is a critical factor in pathological neovascularization, making it the primary target for ocular anti-angiogenic therapies. Anti-VEGF treatments suffer from requiring frequent intraocular injections for effective treatment due to limited half-life. This study aimed to utilize…

  8. A review of the analysis of the effects of nanoparticle morphology on intracellular drug delivery 2026

    Nanoparticles have been used as promising carriers for targeted and controlled drug delivery by researchers due to their unique physicochemical properties, such as size, surface charge, and especially shape. Among these parameters, the shape of nanoparticles has attracted increasing attention because it significantly…

  9. A Patient-Centric Dual-Drug Fast-Dissolving Oral Thin Film of Chlorpheniramine Maleate and Dexamethasone Sodium Phosphate: QbD-Based Development and Optimization 2026

    Özet henüz yok.

  10. In vitro Antimicrobial Activity of Salicylic Acid--Loaded Liposomes Against Cutibacterium acnes: A Microbiological Approach for Acne Treatment 2026

    Objective: This study aimed to comparatively evaluate the antimicrobial activity of free salicylic acid, liposomal salicylic acid, and an arbutin-containing liposomal salicylic acid formulation against Cutibacterium acnes (C. acnes), a key microorganism in the pathogenesis of acne vulgaris, and to assess the contribut…

  11. The role of microemulsion technology in psoriasis treatment: an evaluation in light of clinical and preclinical findings 2026

    Psoriasis is a chronic, inflammatory, and immune mediated dermatological diseases that adversely affects the quality of life of millions of individuals worldwide. Due to its heterogeneous natüre, which varies from patient to patient, and its systemic manifestations, current treatment approaches are often insufficient…

  12. Animal-based experimental models in dry eye research: Current approaches and limitations 2026

    Özet henüz yok.

Akademisyenler

132 akademisyen